These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16325281)

  • 61. Improvement of coronary artery disease in a patient with hyperhomocysteinemia: report of a case.
    Rothkopf MM; Franco A; Usiskin K; Haverstick L; Malone M
    Nutrition; 1998 Sep; 14(9):687-90. PubMed ID: 9760589
    [No Abstract]   [Full Text] [Related]  

  • 62. Hyperhomocysteinemia following oral methionine load is associated with increased lipid peroxidation.
    Domagala TB; Libura M; Szczeklik A
    Thromb Res; 1997 Aug; 87(4):411-6. PubMed ID: 9271819
    [No Abstract]   [Full Text] [Related]  

  • 63. Impairment of coronary circulation by acute hyperhomocysteinemia in type 2 diabetic patients.
    Coppola A; Astarita C; Oliviero M; Fontana D; Picardi G; Esposito K; Marfella R; Coppola L; Giugliano D
    Diabetes Care; 2004 Aug; 27(8):2055-6. PubMed ID: 15277441
    [No Abstract]   [Full Text] [Related]  

  • 64. Another cause of hyperhomocysteinemia.
    Cheng TO
    Hosp Pract (1995); 1997 Aug; 32(8):44. PubMed ID: 9275960
    [No Abstract]   [Full Text] [Related]  

  • 65. [Clinical significance of homocysteine].
    Aguirre Errasti C; Egurbide Arberas MV
    Rev Clin Esp; 2001 Jan; 201(1):25-7. PubMed ID: 11293978
    [No Abstract]   [Full Text] [Related]  

  • 66. The homocysteine question.
    Mann GV
    Lancet; 2000 Apr; 355(9210):1190. PubMed ID: 10791412
    [No Abstract]   [Full Text] [Related]  

  • 67. The microcirculation in coronary ischemia. Are native anticoagulant mechanisms a path to new therapies?
    Berk BC
    Circulation; 1991 Jul; 84(1):439-41. PubMed ID: 2060118
    [No Abstract]   [Full Text] [Related]  

  • 68. Plasma ascorbic acid in heart disease.
    Paolini M; Biagi GL; Cantelli-Forti G; Bauer C
    Lancet; 2001 Jul; 358(9275):71-2. PubMed ID: 11458936
    [No Abstract]   [Full Text] [Related]  

  • 69. Airway strain and coronary disease.
    JAMA; 1973 May; 224(9):1288-9. PubMed ID: 4739896
    [No Abstract]   [Full Text] [Related]  

  • 70. Homocysteine testing.
    Elliott KM
    Crit Care Nurse; 2003 Apr; 23(2):21; author reply 21. PubMed ID: 12725192
    [No Abstract]   [Full Text] [Related]  

  • 71. [Homocysteine as a risk factor for vascular changes].
    Nowakowski P; Wocial B; Berent H; Gurba H
    Pol Arch Med Wewn; 1997 Mar; 97(3):281-6. PubMed ID: 9333775
    [No Abstract]   [Full Text] [Related]  

  • 72. [Don't antioxidants protect against cancer?].
    Røiri P
    Tidsskr Nor Laegeforen; 2005 Jan; 125(2):200. PubMed ID: 15665903
    [No Abstract]   [Full Text] [Related]  

  • 73. Homocysteine and atherothrombosis.
    van Guldener C; Donker AJ; Stehouwer CD
    N Engl J Med; 1998 Aug; 339(7):478; author reply 479. PubMed ID: 9705690
    [No Abstract]   [Full Text] [Related]  

  • 74. [National Homocysteine Meeting Toulouse, September 21, 2000].
    Ann Biol Clin (Paris); 2001; 59(3):339-53. PubMed ID: 11397686
    [No Abstract]   [Full Text] [Related]  

  • 75. Experimental results to the deposition hypothesis of atherosclerosis.
    Müller-Mohnssen H
    Thromb Res; 1976 May; 8(5):553-66. PubMed ID: 936102
    [No Abstract]   [Full Text] [Related]  

  • 76. Homocysteine and coronary microcirculation: is it a microvasculopathic agent?
    Turhan H; Aksoy Y; Yetkin E
    Int J Cardiol; 2006 Jun; 110(2):269-70. PubMed ID: 16325281
    [No Abstract]   [Full Text] [Related]  

  • 77. Experimental hyperhomocysteinemia impairs coronary flow velocity reserve.
    Yamashita K; Tasaki H; Nagai Y; Suzuka H; Nihei S; Kobayashi K; Horiuchi M; Nakashima Y; Adachi T
    Int J Cardiol; 2005 Sep; 104(2):163-9. PubMed ID: 16168809
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Homocysteine and coronary artery disease].
    Aro A
    Duodecim; 2003; 119(12):1131-5. PubMed ID: 12868359
    [No Abstract]   [Full Text] [Related]  

  • 79. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.
    Chambers JC; McGregor A; Jean-Marie J; Obeid OA; Kooner JS
    Circulation; 1999 Mar; 99(9):1156-60. PubMed ID: 10069782
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Homocysteine and endothelial function in human studies.
    Moat SJ; McDowell IF
    Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.